Column Group LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001833486 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 12, 2021

Total Value: $879M (100.0% shares, 0.0% debt)

Holdings (7)

— NGM Biopharmaceuticals Inc 36.8%

Value $324M Shares 15,396,116 Est. Cost $30.30 Unrealized —

TNYA Tenaya Therapeutics, Inc. 22.1%

Value $194M Shares 9,400,290 Est. Cost $21.49 Unrealized 0.0%

ORIC ORIC Pharmaceuticals Inc. 11.3%

Value $99.7M Shares 4,768,181 Est. Cost $28.69 Unrealized -29.3%

RVMD Revolution Medicines Inc 10.5%

Value $92.08M Shares 3,347,245 Est. Cost $39.54 Unrealized -26.4%

— Surrozen, Inc. 7.4%

Value $65.48M Shares 9,248,129 Est. Cost $7.08 Unrealized —

— eFFECTOR Therapeutics Inc 6.9%

Value $60.55M Shares 4,309,329 Est. Cost $14.05 Unrealized —

— RAPT Therapeutics Inc 5.0%

Value $43.53M Shares 1,402,008 Est. Cost $19.75 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	NGM Biopharmaceuticals Inc	15,396,116	$324M	36.8%	$30.30	—	COM	62921N105
TNYA	Tenaya Therapeutics, Inc.	9,400,290	$194M	22.1%	$21.49	0.0%	COM	87990A106
ORIC	ORIC Pharmaceuticals Inc.	4,768,181	$99.7M	11.3%	$28.69	-29.3%	COM	68622P109
RVMD	Revolution Medicines Inc	3,347,245	$92.08M	10.5%	$39.54	-26.4%	COM	76155X100
—	Surrozen, Inc.	9,248,129	$65.48M	7.4%	$7.08	—	COM	86889P109
—	eFFECTOR Therapeutics Inc	4,309,329	$60.55M	6.9%	$14.05	—	COM	28202V108
—	RAPT Therapeutics Inc	1,402,008	$43.53M	5.0%	$19.75	—	COM	75382E109